You may remember that I was in a clinical trial using Selenium with Carboplatin and Taxol for treatment of ovarian cancer.
Research into selenium and various cancers continues at CINJ. I received this e-mail about a clinical trial at CINJ that will study selenium to reduce the risk of prostate in men.
Healthy male volunteers needed
Researchers at The Cancer Institute of New Jersey (CINJ) are studying the role of the mineral selenium in reducing one's risk for prostate cancer. Consider taking part in this study...and join the team!
CINJ researchers are trying to see if selenium yeast or selenomethionine lower
prostate-specific antigen (PSA) levels and prevent other markers related to the
development of prostate cancer in healthy men of different age groups.
Participants will be asked to take over-the-counter selenium supplements or a placebo
for twelve months.Five visits to CINJ are required during the study, where blood and urine samples will
Compensation is provided.
You may be eligible to participate if you:
Are a healthy male between 20 and 79 years
Have no evidence of prostate cancer
Are a nonsmoker
Can visit CINJ five times over twelve months.
To see if you are eligible for this study,
contact Michelle Orlick at 732-235-6048 or
Every day is a Blessing!